<DOC>
	<DOCNO>NCT01319461</DOCNO>
	<brief_summary>Evaluate efficacy safety Hyalgan , dose 20mg/2ml administer 5 intraarticular injection weekly interval , sustain relief pain amelioration joint dysfunction patient OA knee .</brief_summary>
	<brief_title>Efficacy Safety Intraarticular Injections Hyalgan Treatment Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1.Male female patient whose specific age &gt; 50 year old , general health . 2.Must ambulatory ( assistive device allow ) 3.Patient diagnosed OA knee joint American College Rheumatology ( ACR ) criterion ; [ ie , knee pain , one following : age &gt; 50 year , crepitus , morning stiffness &lt; 30 minute duration ] 4.Radiographic confirmation OA KellgrenLawrence ⅡⅢ score ( mild moderate ) target joint ( anteriorposterior view ) predominance tibiafemoral compartment 5.VAS score ≧40 mm 50 foot walk pain . 1.Patients severe degeneration knee joint mark joint narrowing , mark varus valgus deformity knee great 12 . 2.Patients hepatic renal failure , chronic severe disease interfere outcome . 3.A known history psychiatric disease , significant neurological disease , allergy sensitivity hyaluronic acid avian protein . 4.Patients receive steroid intraarticular injection , antiinflammatory agent less two week . 5.Patients joint disorder : inflammatory joint disease , specific arthropathy ( chondrocalcinosis , joint effusion &gt; 30ml ) , severe axis deviation instability , joint skin infection , joint prosthesis low limb , symptomatic hip . 6.Significant alcohol , drug medication abuse judged investigator . 7.Pregnancy determine clinical evaluation urine test nursing woman and/or woman childbearing potential use medically approve mean contraception ( i.e. , oral contraceptive , intrauterine device , diaphragm Norplant ) . 8.Patients take `` investigational '' drug within one month prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Hyalgan</keyword>
</DOC>